3'-o-(4-benzoyl)benzoyladenosine 5'-triphosphate has been researched along with Multiple Sclerosis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Amor, S; Baselmans, B; Bol, JG; Brevé, JJ; de Vries, HE; Deckard, SA; Drukarch, B; Dutta, R; Prins, M; Trapp, BD; van Dam, AM; van der Valk, P | 1 |
Brosnan, CF; Lee, SC; Narcisse, L; Scemes, E; Zhao, Y | 1 |
2 other study(ies) available for 3'-o-(4-benzoyl)benzoyladenosine 5'-triphosphate and Multiple Sclerosis
Article | Year |
---|---|
Discrepancy in CCL2 and CCR2 expression in white versus grey matter hippocampal lesions of Multiple Sclerosis patients.
Topics: Adenosine Triphosphate; Adult; Aged; Animals; Animals, Newborn; Bromodeoxyuridine; Cell Proliferation; Cells, Cultured; Chemokine CCL2; Female; Gene Expression; Gray Matter; Hippocampus; Histocompatibility Antigens Class II; Humans; Male; Middle Aged; Multiple Sclerosis; Myelin Basic Protein; Neuroglia; Platelet Aggregation Inhibitors; Rats; Rats, Wistar; Receptors, CCR2; White Matter | 2014 |
The cytokine IL-1beta transiently enhances P2X7 receptor expression and function in human astrocytes.
Topics: Adenosine Triphosphate; Astrocytes; Benzoxazoles; Calcium Signaling; Cell Membrane; Cells, Cultured; Encephalitis; Fluorescent Dyes; Humans; Interleukin-1; Multiple Sclerosis; Nitric Oxide; Protein Transport; Quinolinium Compounds; Receptors, Purinergic P2; Receptors, Purinergic P2X7; RNA, Messenger; Signal Transduction; Up-Regulation | 2005 |